Bowmed Ibisqus is a wholly owned subsidiary of the Ibigen Group, headquartered in Italy. For over 100 years, this family-owned group has been producing and distributing injectable products worldwide.  As a leader in the production of β-lactam antibiotics and hospital therapy products, Ibigen is recognised for its expertise in aseptic dosing and β-lactam formulations. The group operates as a fully integrated, vertical company managing every stage from product development, registration, API sourcing, manufacturing and sales distribution.